Exploring trends and predictors of long-term asthma remission

Area of Science:

• Pulmonology
• Immunology
• Clinical Medicine

Background:

• Asthma remission, defined as minimal disease activity, is poorly understood regarding long-term achievement and predictors.
• Understanding these factors is crucial for improving patient outcomes and treatment strategies.

Purpose of the Study:

• To identify clinical predictors and trends of long-term asthma remission in adults with mild to severe asthma.
• To assess the achievability of sustained remission over a 6-year period.

Main Methods:

• A 6-year longitudinal study of 203 adults with mild to severe asthma.
• Assessed type 2 inflammation markers, lung function (oscillometry, spirometry), atopy, and comorbidities.
• Defined clinical remission (ACT score ≥20, no severe exacerbations/steroids, normal/stable lung function) and long-term remission (≥3 consecutive years).

Main Results:

• 27% achieved long-term remission; 16% of severe asthma patients vs. 65% of mild-to-moderate.
• Over one-third never achieved remission, often with persistent type 2 markers.
• Predictors of no remission included T2 markers, small airway dysfunction, airflow obstruction, GERD, CVD, and dyslipidemia; house dust mite sensitization predicted remission.

Conclusions:

• Long-term asthma remission is challenging, particularly for those with persistent type 2 inflammation and impaired lung function.
• Early targeting of type 2 inflammation may be necessary to prevent irreversible lung function impairment.
• Highlights a significant unmet need in asthma management.